AMP-activated protein kinase suppresses LXR-dependent sterol regulatory element-binding protein-1c transcription in rat hepatoma McA-RH7777 cells

Journal of Cellular Biochemistry

Volumn 106, Issue 3, 2009, Pages 414-426

  Yang, Jian ^a,b   Craddock, Lauren ^a   Hong, Sharon ^a   Liu, Zhi Mei ^a  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^b 307 University Boulevard ^*  (United States)

Author keywords

Ampk; Liver gene expression; Mca rh7777 cells; Srebp 1c; Transcription

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; DACTINOMYCIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MESSENGER RNA; METFORMIN; N (2,2,2 TRIFLUOROETHYL) N [4 (2,2,2 TRIFLUORO 1 HYDROXY 1 TRIFLUOROMETHYLETHYL)PHENYL]BENZENESULFONAMIDE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1A; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; ABC TRANSPORTER; ABCG5 PROTEIN, RAT; ABCG8 PROTEIN, RAT; ADENOSINE PHOSPHATE; CELL RECEPTOR; DNA BINDING PROTEIN; LIGAND; LIPOPROTEIN; LIVER X RECEPTOR; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; HEPATOMA CELL; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; RAT; ACTIVE TRANSPORT; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PROMOTER REGION; TUMOR CELL LINE;

RATTUS;

ACTIVE TRANSPORT, CELL NUCLEUS; ADENOSINE MONOPHOSPHATE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE, TUMOR; DNA-BINDING PROTEINS; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; LIGANDS; LIPOPROTEINS; PROMOTER REGIONS, GENETIC; RATS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANSCRIPTION, GENETIC;

EID: 62649093597     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22024     Document Type: Article

References (56)

1. Amemiya-Kudo M, Shimano H, Yoshikawa T, Yahagi N, Hasty AH, Okazaki H, Tamura Y, Shionoiri F, lizuka Y, Ohashi K, Osuga J, Harada K, Gotoda T, Sato R, Kimura S, Ishibashi S, Yamada N. 2000. Promoter analysis of the mouse sterol regulatory element-binding protein-1c gene. J Biol Chem 275:31078-31085.
2. Assifi MM, Suchankova G, Constant S, Prentki M, Saha AK, Ruderman NB. 2005. AMP-activated protein kinase and coordination of hepatic fatty acid metabolism of starved/carbohydrate-refed rats. Am J Physiol Endocrinol Metab 289:E794-E800.
3. Brown MS, Goldstein JL. 1997. The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89:331-340.
4. Brown MS, Goldstein JL. 1999. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc Natl Acad Sci USA 96:11041-11048.
5. Brown MS, Goldstein JL. 2008. Selective versus total insulin resistance: A pathogenic paradox. Cell Metab 7:95-96.
6. Cagen LM, Deng X, Wilcox HG, Park EA, Raghow R, Elam MB. 2005. Insulin activates the rat sterol-regulatory-element-binding protein 1c (SREBP-lc) promoter through the combinatorial actions of SREBP, LXR, Sp-1 and NF-Y cis-acting elements. Biochem J 385:207-216.
7. Chen G, Liang G, Ou J, Goldstein JL, Brown MS. 2004. Central role for liver X receptor in insulin-mediated activation of Srebp-lc transcription and stimulation of fatty acid synthesis in liver. Proc Natl Acad Sci USA 101:11245-11250.
8. Chen M, Bradley MN, Beaven SW, Tontonoz P. 2006. Phosphorylation of the liver X receptors. FEES Lett 580:4835-4841.
9. Corton JM, Gillespie JG, Hawley SA, Hardie DG. 1995. 5-aminoimidazole-4- carboxamide ribonucleoside. A. specific method for activating AMP-activated protein kinase in intact cells? Eur J Biochem 229:558-565.
10. Davies SP, Carling D, Hardie DG. 1989. Tissue distribution of the AMP-activated protein kinase, and lack of activation by cyclic-AMP-dependent protein kinase, studied using a specific and sensitive peptide assay. Eur J Biochem 186:123-128.
11. DeBose-Boyd RA, Ou J, Goldstein JL, Brown MS. 2001. Expression of sterol regulatory element-binding protein lc (SREBP-lc) mRNA in rat hepatoma cells requires endogenous LXR ligands. Proc Natl Acad Sci USA 98:1477-1482.
12. Ferre P, Azzout-Marniche D, Foufelle F. 2003. AMP-activated protein kinase and hepatic genes involved in glucose metabolism. Biochem Soc Trans 31:220-223.
13. Foretz M, Ancellin N, Andreelli F, Saintillan Y, Grondin P, Kahn A, Thorens B, Vaulont S, Viollet B. 2005. Short-Term Overexpression of a Constitutively Active Form of AMP-Activated Protein Kinase in the Liver Leads to Mild Hypoglycemia and Fatty Liver. Diabetes 54:1331-1339.
14. Fryer LG, Parbu-Patel A, Carling D. 2002. The Anti-diabetic drugs rosigli-tazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J Biol Chem 277:25226-25232.
15. Goldstein JL, DeBose-Boyd RA, Brown MS. 2006. Protein sensors for membrane sterols. Cell 124:35-46.
16. Hannah VC, Ou J, Luong A, Goldstein JL, Brown MS. 2001. Unsaturated fatty acids down-regulate srebp isoforms la and lc by two mechanisms in HEK-293 cells. J Biol Chem 276:4365-4372.
17. Hardie DG. 2006. AMP-activated protein kinase as a drug target. Annu Rev Pharmacol Toxicol 47:185-210.
18. Hardie DG. 2007. AMP-activated/SNFl protein kinases: Conserved guardians of cellular energy. Nat Rev Mol Cell Biol 8:774-785.
19. Hardie DG, Carling D, Carlson M. 1998. The AMP-activated/SNFl protein kinase subfamily: Metabolic sensors of the eukaryotic cell? Annu Rev Biochem 67:821-855.
20. Hawley SA, Gadalla AE, Olsen GS, Hardie DG. 2002. The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism. Diabetes 51:2420-2425.
21. Hawley SA, Boudeau J, Reid JL, Mustard KJ, Udd L, Makela TP, Alessi DR, Hardie DG. 2003. Complexes between the LKB1 tumor suppressor, STRA-Dalpha/beta and M025alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J Biol 2:28.
22. Hawley SA, Pan DA, Mustard KJ, Ross L, Bain J, Edelman AM, Frenguelli BG, Hardie DG. 2005. Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab 2:9-19.
23. Hegarty BD, Bobard A, Hainault I, Ferre P, Bossard P, Foufelle F. 2005. Distinct roles of insulin and liver X receptor in the induction and cleavage of sterol regulatory element-binding protein-lc. Proc Natl Acad Sci USA 102:791-796.
24. Henin N, VincentMF, Gruber HE, Van den BG. 1995. Inhibition of fatty acid and cholesterol synthesis by stimulation of AMP-activated protein kinase. FASEB J 9:541-546.
25. Horton JD, Bashmakov Y, Shimomura I, Shimano H. 1998. Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice. Proc Natl Acad Sci USA 95:5987-5992.
26. Horton JD, Goldstein JL, Brown MS. 2002. SREBPs: Activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109:1125-1131.
27. Hurley RL, Anderson KA, Franzone JM, Kemp BE, Means AR, Witters LA. 2005. The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J Biol Chem 280:29060-29066.
28. Leff T. 2003. AMP-activated protein kinase regulates gene expression by direct phosphorylation of nuclear proteins. Biochem Soc Trans 31:224-227.
29. Leist M, Gantner F, Bohlinger I, Germann PG, Tiegs Q, Wendel A. 1994. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcriptional arrest. J Immunol 153:1778-1788.
30. Liang G, Yang J, Horton JD, Hammer RE, Goldstein JL, Brown MS. 2002. Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element- binding protein-lc. J Biol Chem 277:9520-9528.
31. Lin HZ, Yang SQ, Chuckaree C, Kuhajda F, Ronnet G, Diehl AM. 2000. Metformin reverses fatty liver disease in obese, leptin-deficient mice. Nat Med 6:998-1003.
32. Meisse D, Van de CM, Beauloye C, Hainault I, Kefas BA, Rider MH, Foufelle F, Hue L. 2002. Sustained activation of AMP-activated protein kinase induces c-Jun N-terminal, kinase activation and apoptosis in liver cells. FEES Lett 526:38-42.
33. Momcilovic M, Hong SP, Carlson M. 2006. Mammalian TAK1 activates Snfl protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro. J Biol Chem 281:25336-25343.
34. Munday MR, Milic MR, Takhar S, Holness MJ, Sugden MC. 1991. The short-term regulation of hepatic acetyl-CoA carboxylase during starvation and re-feeding in the rat. Biochem J 280(Pt 3):733-737.
35. Musi N, Hirshman MF, Nygren J, Svanfeldt M, Bavenholm P, Rooyackers O, Zhou G, Williamson JM, Ljunqvist O, Efendic S, Moller DE, Thorell A Goodyear LJ. 2002. Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. Diabetes 51:2074-2081.
36. Repa JJ, Liang G, Ou J, Bashmakov Y, Lobaccaro JM, Shimomura I, Shan B, Brown MS, Goldstein JL, Mangelsdorf DJ. 2000. Regulation of mouse sterol regulatory element-binding protein-lc gene (SREBP-lc) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev 14:2819-2830.
37. Repa JJ, Berge KE, Pomajzl C, Richardson JA, Hobbs H, Mangelsdorf DJ. 2002. Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. J Biol Chem 277:18793-18800.
38. Saha AK, Avilucea PR, Ye JM, Assifi MM, Kraegen EW, Ruderman NB. 2004. Pioglitazone treatment activates AMP-activated protein kinase in rat liver and adipose tissue in vivo. Biochem Biophys Res Commun 314:580-585.
39. Sato R, Goldstein JL, Brown MS. 1993. Replacement of serine-871 of hamster 3-hydroxy-3-methylglutaryl-CoA reductase prevents phosphorylation by AMP-activated kinase and blocks inhibition of sterol synthesis induced by ATP depletion. Proc Natl Acad Sci USA 90:9261-9265.
40. Shaw RJ, Kosmatka M, Bardeesy N, Hurley RL, Witters LA, DePinho RA, Cantley LC. 2004. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc Natl Acad Sci USA 101:3329-3335.
41. Shaw RJ, Lamia KA, Vasquez D, Koo SH, Bardeesy N, DePinho RA, Montminy M, Cantley LC. 2005. The Kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310:1642-1646.
42. Shimomura I, Shimano H, Horton JD, Goldstein JL, Brown MS. 1997. Differential expression of exons la and lc in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells. J Clin Invest 99:838-845.
43. Shimomura I, Bashmakov Y, Horton JD. 1999. Increased levels of nuclear SREBP-lc associated with fatty livers in two mouse models of diabetes mellitus. J Biol Chem 274:30028-30032.
44. Stein SC, Woods A, Jones NA, Davison MD, Carling D. 2000. The regulation of AMP-activated protein kinase by phosphorylation. Biochem J 345(Pt 3): 437-443.
45. Tobin KA, Steineger HH, Alberti S, Spydevold O, Auwerx J, Gustafsson JA, Nebb HI. 2000. Cross-talk between fatty acid and cholesterol metabolism mediated by liver X receptor-alpha. Mol Endocrinol 14:741-752.
46. Viollet B, Foretz M, Guigas B, Horman S, Dentin R, Bertrand L, Hue L, Andreelli F. 2006. Activation of AMP-activated protein kinase in the liver: A new strategy for the management of metabolic hepatic disorders. J Physiol 574:41-53.
47. Wang W, Fan J, Yang X, Furer-Galban S, Lopez de Silanes I, von Kobbe C, Guo J, Georas SN, Foufelle F, Hardie DG, Carling D, Gorospe M. 2002. AMP- activated kinase regulates cytoplasmic HuR. Mol Cell Biol 22:3425-3436.
48. Witters LA, Gao G, Kemp BE, Quistorff B. 1994. Hepatic 5'-AMP-activated protein kinase: Zonal distribution and relationship to acetyl-CoA carboxylase activity in varying nutritional states. Arch Biochem Biophys 308:413-419.
49. Woods A, Johnstone SR, Dickerson K, Leiper FC, Fryer LG, Neumann D, Schlattner U, Wallimann T, Carlson M, Carling D. 2003. LKB 1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol 13:2004-2008.
50. Woods A Dickerson K, Heath R, Hong SP, Momcilovic M, Johnstone SR, Carlson M, Carling D. 2005. C(Ca2+)/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab 2:21-33.
51. Xu J, Teran-Garcia M, Park JH, Nakamura MT, Clarke SD. 2001. Polyunsaturated fatty acids suppress hepatic sterol regulatory element-binding protein-1 expression by accelerating transcript decay. J Biol Chem 276:9800-9807.
52. Yamamoto T, Shimano H, Inoue N, Nakagawa Y, Matsuzaka T, Takahashi A, Yahagi N, Sone H, Suzuki H, Toyoshima H, Yamada N. 2007. Protein kinase A suppresses sterol regulatory element-binding protein-1C expression via phosphorylation of liver X receptor in the liver. J Biol Chem 282:11687-11695.
53. Yang J, Goldstein JL, Hammer RE, Moon YA, Brown MS, Horton JD. 2001. Decreased lipid synthesis in livers of mice with disrupted Site-1 protease gene. Proc Natl Acad Sci USA 98:13607-13612.
54. Yang J, Maika S, Craddock L, King JA, Liu ZM. 2008. Chronic activation of AMP-activated protein kinase-alpha l in liver leads to decreased adiposity in mice. Biochem Biophys Res Commun 370:248-253.
55. Zang M, Zuccullo A, Hou X, Nagata D, Walsh K, Herscovitz H, Brecher P, Ruderman NB, Cohen RA. 2004. AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells. J Biol Chem 279:47898-47905.
56. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, DoebberT, Fujii N, Musi N, Hirshman MF, Goodyear LJ, MollerDE. 2001. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108:1167-1174.